{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:02:22Z","timestamp":1781830942489,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670933"],"award-info":[{"award-number":["31670933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401669"],"award-info":[{"award-number":["81401669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371817"],"award-info":[{"award-number":["81371817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vaccine.2016.10.018","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T01:49:02Z","timestamp":1476928142000},"page":"5938-5945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice"],"prefix":"10.1016","volume":"34","author":[{"given":"Lisheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaona","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.018_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.018_b0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jfma.2012.12.001","article-title":"Is a monovalent vaccine against enterovirus 71 sufficient? A review of enterovirus 71 vaccine development based on enterovirus surveillance in Taiwan","volume":"112","author":"Chu","year":"2013","journal-title":"J Formosan Med Assoc = Taiwan yi zhi"},{"key":"10.1016\/j.vaccine.2016.10.018_b0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.10.018_b0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.10.018_b0025","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/21645515.2015.1049780","article-title":"Is a multivalent hand, foot, and mouth disease vaccine feasible?","volume":"11","author":"Klein","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.10.018_b0030","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.018_b0035","doi-asserted-by":"crossref","first-page":"670506","DOI":"10.1155\/2014\/670506","article-title":"Immunogenicity studies of bivalent inactivated virions of EV71\/CVA16 formulated with submicron emulsion systems","volume":"2014","author":"Lin","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vaccine.2016.10.018_b0040","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.018_b0045","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.10.018_b0050","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2014.08.064","article-title":"Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.018_b0055","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microb Infect\/Inst Pasteur"},{"key":"10.1016\/j.vaccine.2016.10.018_b0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.10.018_b0065","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.018_b0070","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.018_b0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0166-3542(02)00073-6","article-title":"Chimeric hepatitis A virus particles presenting a foreign epitope (HIV gp41) at their surface","volume":"55","author":"Beneduce","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2016.10.018_b0080","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.85.9.3203","article-title":"Poliovirus type 1\/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys","volume":"85","author":"Murray","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.10.018_b0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.7.4.14422","article-title":"Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy","volume":"7","author":"Kim","year":"2011","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.018_b0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jviromet.2015.02.010","article-title":"Development of a coxsackievirus A16 neutralization test based on the enzyme-linked immunospot assay","volume":"215\u2013216","author":"Hou","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.10.018_b0095","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.10.018_b0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2015.08.002","article-title":"Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice","volume":"210","author":"Yang","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.10.018_b0105","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s00253-016-7296-z","article-title":"Development of sandwich ELISAs that can distinguish different types of coxsackievirus A16 viral particles","volume":"100","author":"Ye","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2016.10.018_b0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/CVI.00359-13","article-title":"Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3","volume":"21","author":"Yang","year":"2014","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2016.10.018_b0115","doi-asserted-by":"crossref","first-page":"e79599","DOI":"10.1371\/journal.pone.0079599","article-title":"The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy Chinese infants and children","volume":"8","author":"Mao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.018_b0120","doi-asserted-by":"crossref","first-page":"e109391","DOI":"10.1371\/journal.pone.0109391","article-title":"In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.018_b0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/thno.7457","article-title":"Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop","volume":"4","author":"Xu","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.vaccine.2016.10.018_b0130","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.10.018_b0135","doi-asserted-by":"crossref","first-page":"e92719","DOI":"10.1371\/journal.pone.0092719","article-title":"Phenotypic and genotypic characteristics of novel mouse cell line (NIH\/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv)","volume":"9","author":"Victorio","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.018_b0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2016.06.014","article-title":"Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology","volume":"132","author":"Yang","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2016.10.018_b0145","doi-asserted-by":"crossref","first-page":"e0123944","DOI":"10.1371\/journal.pone.0123944","article-title":"Identification of broad-genotype HPV L2 neutralization site for pan-HPV vaccine development by a cross-neutralizing antibody","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.018_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2015.08.004","article-title":"Molecular insights into the inhibition of HIV-1 infection using a CD4 domain-1-specific monoclonal antibody","volume":"122","author":"Hou","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2016.10.018_b0155","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.018_b0160","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1038\/srep07878","article-title":"Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2016.10.018_b0165","series-title":"BIT\u2019s 7th annual world congress of vaccine. Nanjing, China","first-page":"213","article-title":"Design of a recombinant enterovirus 71 harboring coxsackievirus A16 neutralizing epitope-a novel bivalent vaccine against HFMD","author":"Zhao","year":"2015"},{"key":"10.1016\/j.vaccine.2016.10.018_b0170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2016.10.018_b0175","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1128\/JVI.00422-15","article-title":"Crystal structures of yeast-produced enterovirus 71 and enterovirus 71\/coxsackievirus A16 chimeric virus-like particles provide the structural basis for novel vaccine design against hand-foot-and-mouth disease","volume":"89","author":"Lyu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.10.018_b0180","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/14712598.2014.935330","article-title":"Update on the development of enterovirus 71 vaccines","volume":"14","author":"Kung","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2016.10.018_b0185","doi-asserted-by":"crossref","first-page":"12973","DOI":"10.1038\/srep12973","article-title":"A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71","volume":"5","author":"Xu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2016.10.018_b0190","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.018_b0195","doi-asserted-by":"crossref","first-page":"10500","DOI":"10.1128\/JVI.01102-15","article-title":"Structures of coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicity","volume":"89","author":"Ren","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.10.018_b0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jviromet.2013.06.009","article-title":"Specific primer amplification of the VP1 region directed by 5\u2032 UTR sequence analysis: enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients","volume":"193","author":"Ge","year":"2013","journal-title":"J Virol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T11:52:03Z","timestamp":1536321123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16309343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0264410X16309343"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}